Measles is surging in the U.S. — and outbreaks can cost millions
A measles advisory is shown tacked to a bulletin board outside Gaines County Courthouse in Seminole, Texas, April 9, 2025.Brandon...
Pharmaceuticals
Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
Healthcare stocks may struggle to gain momentum as Democrats prepare to take over Congress.Jared Holz, who covers healthcare for Mizuho,...
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Moderna on Friday smashed third-quarter revenue and earnings estimates and hiked its outlook for full-year sales growth, as some of...
CVS Health plans to split itself up. Here's why a breakup could make sense now
The CVS logo is displayed at a CVS store on May 06, 2026 in Los Angeles, California.Mario Tama | Getty...
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
Merck on Thursday topped third-quarter estimates and hiked its adjusted profit outlook, as its immunotherapy Keytruda, including a newer injectable...
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart plans to cover more than 250 prescriptions, including some insulin, inhalers and GLP-1s for diabetes, at no cost to...
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Photo illustration of a group of weight loss medications on a white background.Ucg | Universal Images Group | Getty ImagesThe...
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersEvery time Novo urges investors to look ahead,...
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
President Donald Trump makes an announcement about lowering the cost of drug prices, at the Roosevelt Room of the White...
Most Americans aren't anti-vaccine. They're uncertain — and that's a growing public health challenge
Vials of measles-mumps-rubella vaccine are displayed on a counter at a Walgreens Pharmacy in Mill Valley, California, Jan. 26, 2015.Justin...
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit...
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, March...
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player in the...
Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line
Cheng Xin | Getty Images News | Getty ImagesHumana on Wednesday reported second-quarter results that topped estimates, as the health...
Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
The increased use of weight-loss drugs has created a big opportunity for aesthetics company Galderma, its CEO told CNBC on...
What to know about testosterone replacement therapy as the U.S. military plans to test troops
US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on April 8,...
UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company...
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle....
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed to meet...
French biotech stock soars 34% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease,...
